Top

Published in:

01-10-2023 | Vasculitis | News item

Azacitadine-related cutaneous vasculitis

Published in: Reactions Weekly | Issue 1/2023

Excerpt

After considering evidence in EudraVigilance and literature, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency has agreed that a causal relationship between injectable formulations of azacitadine and cutaneous vasculitis is at least a reasonable possibility. …

Azacitidine - Cutaneous vasculitis Internet Document : 23 Oct 2023. Available from: URL: https://www.ema.europa.eu/en/documents/committee-report/prac-recommendations-signals-adopted-25-28-september-2023-prac_.pdf

Title: Azacitadine-related cutaneous vasculitis
Publication date: 01-10-2023
Publisher: Springer International Publishing
Keywords: Vasculitis
Vasculitis
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-48193-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Azacitadine-related cutaneous vasculitis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Disease modifying antirheumatics/tocilizumab

Capecitabine/cisplatin/gemcitabine

Nirmatrelvir+ritonavir/ruxolitinib interaction

Lithium/propranolol

Antibacterials/immunosuppressants/steroids

Escitalopram